Michael Link
Academic Appointments
- Professor, Pediatrics - Hematology/Oncology
- Member, Cancer Center
Contact Information
-
Clinical Offices
Pediatric Hematology/Oncology 725 Welch Rd Palo Alto, CA 94304 Tel Work (650) 497-8953 Fax (650) 497-8101Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
Professional Snapshot
Clinical Focus
- Hematology/Oncology/Stem Cell Transplant, Pediatric
- Pediatric Hematology-Oncology
Administrative Appointments
- Director, Center for Cancer and Blood Diseases, Lucile Packard Children's Hospital at Stanford (2002 - present)
- Chief, Division of Pediatric Hematology/Oncology, Stanford University School of Medicine (2000 - present)
- Lydia J. Lee Professor in Pediatric Cancer, Stanford University (2003 - present)
Honors and Awards
- Annual Memorial Lectureship, Pediatric Cancer Research Foundation (2004)
- Ben Abelson Memorial Visiting Professor, Washington University School of Medicine (2000)
- Alpha Omega Alpha, Alpha Omega Alpha (1974)
- Phi Beta Kappa, Phi Beta Kappa (1969)
Professional Education
| Board Certification: | Pediatric Hematology-Oncology, American Board of Pediatrics (1980) |
| Board Certification: | General Pediatrics, American Board of Pediatrics (1979) |
| Fellowship: | Dana-Farber Cancer Institute, MA (1979) |
| Fellowship: | Children's Hospital of Boston, MA (1979) |
| Residency: | Children's Hospital of Boston, MA (1976) |
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Saint Jude Childrens Research Hospital |
Scientific Focus
Research Interests
Hematology/Oncology, treatment of sarcomas of bone and soft tissue, biology of acute lymphoblastic leukemias, treatment of non-Hodgkin's lymphoma and Hodgkin's disease.
Clinical Trials
- A Phase 2 Open Label Trial of SGN-35 for Systemic Anaplastic Large Cell Lymphoma Recruiting
- Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin's Disease Recruiting
- Reduced Duration Standford V Chemotherapy With Low-Dose Tailored-Field Radiation For Favorable Risk Pediatric Hodgkin Lymphoma Recruiting
- Therapy for Pediatric Hodgkin Lymphoma Recruiting
Publications
- The impact of the privacy rule on cancer research: variations in attitudes and application of regulatory standards. J Clin Oncol. 2009; (24): 4014-20
- Nodular lymphocyte-predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: a case report with pathologic, immunophenotypic, and molecular findings. Appl Immunohistochem Mol Morphol. 2008; (2): 196-201
- Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol. 2007; (3): 332-7
- Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol. 2005; (9): 2004-11
- Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature. Pediatr Blood Cancer. 2005; (3): 270-6
Help